Northwestern Mutual Wealth Management Co. Has $75.59 Million Position in The Clorox Company $CLX

Northwestern Mutual Wealth Management Co. raised its position in The Clorox Company (NYSE:CLX) by 6,907.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 749,703 shares of the company’s stock after purchasing an additional 739,005 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Clorox were worth $75,593,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after buying an additional 514 shares during the last quarter. Woodline Partners LP raised its holdings in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares during the period. Baird Financial Group Inc. raised its holdings in Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after acquiring an additional 424 shares during the period. Jump Financial LLC raised its holdings in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after acquiring an additional 7,924 shares during the period. Finally, Bank of Nova Scotia raised its holdings in Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,352 shares during the period. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $90.47 on Monday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $136.69. The firm has a market cap of $10.94 billion, a P/E ratio of 14.69, a P/E/G ratio of 0.47 and a beta of 0.59. The company’s 50-day moving average price is $101.99 and its two-hundred day moving average price is $106.90.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm earned $1.45 EPS. The business’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts anticipate that The Clorox Company will post 5.63 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.5%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio (DPR) is presently 80.52%.

Analysts Set New Price Targets

CLX has been the topic of several research analyst reports. Citigroup lowered their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Morgan Stanley lowered their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. BNP Paribas Exane lowered their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Wells Fargo & Company lowered their price target on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Finally, Royal Bank Of Canada lowered their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $103.73.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.